cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG Oral Tablet
RxNorm concept 1721613, clinical drug (scd).
- RxCUI
- 1721613
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1721613 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG (as tenofovir alafenamide fumarate 11.2 MG) Oral Tablet
Related concepts
- emtricitabine 200 MG (SCDC, consists of)
- cobicistat 150 MG (SCDC, consists of)
- elvitegravir 150 MG (SCDC, consists of)
- tenofovir alafenamide 10 MG (SCDC, consists of)
- Oral Tablet (DF, has dose form)
- cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG Oral Tablet [Genvoya] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1721613 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1721613 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1721613. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.